PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE

Clinical case of a patient with idiopathic pulmonary hypertension, an algorithm for the diagnosis and management of patients with this pathologyare presented in the paper.

Saved in:

Bibliographic Details
Main Authors:	D. V. Madeeva, O. M. Drapkina, M. R. Skhirtladze, I. E. Sergeev, V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	pulmonary hypertension systolic pulmonary artery pressure idiopathic pulmonary hypertension
Online Access:	https://klinitsist.abvpress.ru/Klin/article/view/86
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Idiopathic Pulmonary Hypertension and in Situ Thromboembolism: A Difficult Case in Clinical Practice
by: M. A. Us, et al.
Published: (2024-01-01)

LEFT MAIN CORONARY ARTERY COMPRESSION SYNDROME IN PATIENT WITH PULMONARY ARTERIAL HYPERTENSION. FIRST CLINICAL EXPERIENCE
by: A. N. Bykov, et al.
Published: (2018-12-01)

ORAL ANTICOAGULANTS IN PATIENTS WITH DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION, ASPECTS OF THE PROBLEM
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
by: E. A. Rezukhina, et al.
Published: (2021-09-01)

Lung transplantation for idiopathic pulmonary arterial hypertension: perioperational features
by: V. N. Poptsov, et al.
Published: (2019-01-01)

EXPERIENCE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS MANAGEMENT IN URAL FEDERAL DISTRICT: FEATURES OFOUTPATIENT-HOSPITAL INTERACTIONS
by: S. V. Shalaev, et al.
Published: (2019-03-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

Pulmonary artery denervation in patients with pulmonary hypertension: present state and clinical experience
by: D. A. Feshchenko, et al.
Published: (2019-12-01)

Changing “portrait” of patients with newly diagnosed idiopathic pulmonary hypertension over the past two decades
by: A. M. Shariya, et al.
Published: (2024-10-01)

Evaluation of radiographic pulmonary artery diameter and echocardiographic pulmonary artery pressure in COPD patients in South-West Nigeria
by: Zuliat A. Awoyemi, et al.
Published: (2025-07-01)

The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension
by: Faye E. Smits, et al.
Published: (2024-09-01)

Results of long-term riociguat therapy, including a switching strategy from sildenafil, in patients with pulmonary hypertension of various genesis
by: S. A. Musashaykhova, et al.
Published: (2023-11-01)

THE ROLE OF RADIATION DIAGNOSTIC TECHNIQUES IN THE DIAGNOSIS OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: E. A. Mershina, et al.
Published: (2016-07-01)

THE EFFICACY OF SILDENAFIL THERAPY IN PATIENTS WITH PULMONARY HYPERTENSION OF DIFFERENT ETIOLOGY: INFLUENCE ON THE CLINICAL, FUNCTIONAL, HEMODYNAMIC STATUS, STRUCTURE AND FUNCTION OF THE RIGHT AND LEFT HEART, RIGHT VENTRICULAR-ARTERIAL COUPLING
by: T. V. Martynyuk, et al.
Published: (2017-03-01)

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study
by: Dunbar Ivy, et al.
Published: (2021-07-01)

Assessment of right ventricle–to–pulmonary artery coupling by three-dimensional echocardiography in pre-capillary pulmonary hypertension: comparison with tricuspid annular plane systolic excursion /systolic pulmonary artery pressure ratio
by: Guangjie Lv, et al.
Published: (2025-04-01)

Screening and management of pulmonary arterial hypertension in systemic sclerosis
by: Vivek Nagaraja, et al.
Published: (2017-01-01)

Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiation
by: E. A. Rezukhina, et al.
Published: (2023-03-01)

Performance of Risk‐Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi‐Ethnic Asian Population
by: Haowen Jiang, et al.
Published: (2025-01-01)

Evaluation of pulmonary embolism patients in a tertiary hospital with clinical, radiological and laboratory features
by: Emre Bacaksız, et al.
Published: (2025-07-01)

EFFICACY AND SAFETY OF INHALED NITRIC OXIDE USE IN PATIENTS WITH PULMONARY HYPERTENSION AND CHRONIC HEART FAILURE III-IV FUNCTIONAL CLASS, SURVIVED LEFT VENTRICULAR MYOCARDIAL INFARCTION: RESULTS OF NON-RANDOMIZED COMAPARIVE STUDY
by: P. N. Pavlenko, et al.
Published: (2014-07-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

The multidisciplinary management of pulmonary arterial hypertension patients in pregnancy and postpartum: A case series
by: Jasmine N. Edghill, et al.
Published: (2025-07-01)

A clinical case of radiofrequency pulmonary artery denervation for treatment of a patient with residual chronic thromboembolic pulmonary hypertension
by: D. A. Feshchenko, et al.
Published: (2019-12-01)

Hemodynamic and Genetic Associations with the Risk of Idiopathic Pulmonary Arterial Hypertension Development in an Ethnic Cohort of Kazakhs
by: Dana Taizhanova, et al.
Published: (2024-11-01)

Pulmonary hypertension as a risk assessment factor for unfavorable outcome in patients with COVID-19
by: E. Z. Golukhova, et al.
Published: (2020-12-01)

New therapies in pulmonary arterial hypertension: Recent insights
by: Giulia Guglielmi, et al.
Published: (2025-03-01)

Pulmonary artery pseudoaneurysm in a young man with pulmonary hypertension on computed tomography angiography
by: Tairkhan B. Dautov, et al.
Published: (2024-12-01)

Pulmonary Hypertension in Women
by: Eunwoo Park, et al.
Published: (2024-03-01)

Pathogenetic features of pulmonary hypertension in systemic sclerosis
by: V. S. Vasenina, et al.
Published: (2025-07-01)

Russian consensus: balloon pulmonary angioplasty in treatment of chronic thromboembolic pulmonary hypertension
by: N. M. Danilov, et al.
Published: (2025-03-01)

Historical milestones in the study of pulmonary hypertension
by: Anna K. Osokina, et al.
Published: (2025-01-01)

COVID-19 pandemic challenges: on the way to overcome obstacles in realization of PAH-specific therapy treatment goals
by: E. A. Rezukhina, et al.
Published: (2021-11-01)

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)

Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation
by: Alban Todesco, et al.
Published: (2024-07-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023)
by: I. E. Chazova, et al.
Published: (2024-03-01)

Clinical outcomes of pregnancy in patients with pulmonary hypertension: A single center observational study
by: Jianrong Pan, et al.
Published: (2025-04-01)

Cryoablation method for pulmonary artery sympathetic denervation in patients with pulmonary hypertension secondary to left sided heart disease: interventional technique, safety and results of the hospital phase
by: D. A. Feshchenko, et al.
Published: (2019-09-01)

Balloon Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Lauren N. Carlozzi, et al.
Published: (2024-05-01)